526 related articles for article (PubMed ID: 16426869)
61. Levetiracetam for the treatment of status epilepticus.
Zheng F; Du C; Wang X
Expert Rev Neurother; 2015 Oct; 15(10):1113-21. PubMed ID: 26416394
[TBL] [Abstract][Full Text] [Related]
62. Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model.
Gibbs JE; Cock HR
Epilepsy Res; 2007 Feb; 73(2):208-12. PubMed ID: 17085017
[TBL] [Abstract][Full Text] [Related]
63. Efficacy and safety of levetiracetam as adjunctive treatment of refractory partial seizures in a multicentre open-label single-arm trial in Korean patients.
Heo K; Lee BI; Yi SD; Huh K; Kim JM; Lee SA; Shin DJ; Song HK; Lee SK; Kim JY; Lu S; Dubois C; Tonner F
Seizure; 2007 Jul; 16(5):402-9. PubMed ID: 17369059
[TBL] [Abstract][Full Text] [Related]
64. Intravenous lacosamide or phenytoin for treatment of refractory status epilepticus.
Kellinghaus C; Berning S; Stögbauer F
Acta Neurol Scand; 2014 May; 129(5):294-9. PubMed ID: 23937330
[TBL] [Abstract][Full Text] [Related]
65. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
[TBL] [Abstract][Full Text] [Related]
66. Effect of levetiracetam in acute encephalitis with refractory, repetitive partial seizures during acute and chronic phase.
Ueda R; Saito Y; Ohno K; Maruta K; Matsunami K; Saiki Y; Sokota T; Sugihara S; Nishimura Y; Tamasaki A; Narita A; Imamura A; Maegaki Y
Brain Dev; 2015 May; 37(5):471-7. PubMed ID: 25174548
[TBL] [Abstract][Full Text] [Related]
67. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
van Vliet EA; Edelbroek PM; Gorter JA
Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
[TBL] [Abstract][Full Text] [Related]
68. Levetiracetam efficacy in children with epilepsy with electrical status epilepticus in sleep.
Chen J; Cai F; Jiang L; Hu Y; Feng C
Epilepsy Behav; 2015 Mar; 44():73-7. PubMed ID: 25632834
[TBL] [Abstract][Full Text] [Related]
69. Termination of complex partial status epilepticus by intravenous levetiracetam.
Schulze-Bonhage A; Hefft S; Oehl B
J Neurol Neurosurg Psychiatry; 2009 Aug; 80(8):931-3. PubMed ID: 17353254
[No Abstract] [Full Text] [Related]
70. Intravenous levetiracetam terminates refractory focal status epilepticus.
Abend NS; Florance N; Finkel RS; Licht DJ; Dlugos DJ
Neurocrit Care; 2009; 10(1):83-6. PubMed ID: 18181032
[TBL] [Abstract][Full Text] [Related]
71. Levetiracetam versus phenytoin in management of status epilepticus.
Chakravarthi S; Goyal MK; Modi M; Bhalla A; Singh P
J Clin Neurosci; 2015 Jun; 22(6):959-63. PubMed ID: 25899652
[TBL] [Abstract][Full Text] [Related]
72. Levetiracetam as an adjunctive analgesic in neoplastic plexopathies: case series and commentary.
Dunteman ED
J Pain Palliat Care Pharmacother; 2005; 19(1):35-43. PubMed ID: 15814513
[TBL] [Abstract][Full Text] [Related]
73. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience.
Grosso S; Zamponi N; Bartocci A; Cesaroni E; Cappanera S; Di Bartolo R; Balestri P
Eur J Paediatr Neurol; 2014 Sep; 18(5):604-8. PubMed ID: 24836405
[TBL] [Abstract][Full Text] [Related]
74. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
Wu XY; Hong Z; Wu X; Wu LW; Wang XF; Zhou D; Zhao ZX; Lv CZ
Epilepsia; 2009 Mar; 50(3):398-405. PubMed ID: 18657175
[TBL] [Abstract][Full Text] [Related]
75. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
76. Prophylactic treatment with levetiracetam after status epilepticus: lack of effect on epileptogenesis, neuronal damage, and behavioral alterations in rats.
Brandt C; Glien M; Gastens AM; Fedrowitz M; Bethmann K; Volk HA; Potschka H; Löscher W
Neuropharmacology; 2007 Aug; 53(2):207-21. PubMed ID: 17585956
[TBL] [Abstract][Full Text] [Related]
77. Intravenous Lacosamide in refractory nonconvulsive status epilepticus.
Mnatsakanyan L; Chung JM; Tsimerinov EI; Eliashiv DS
Seizure; 2012 Apr; 21(3):198-201. PubMed ID: 22244046
[TBL] [Abstract][Full Text] [Related]
78. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
[TBL] [Abstract][Full Text] [Related]
79. Efficacy and safety of levetiracetam 1000-3000 mg/day in patients with refractory partial-onset seizures: a multicenter, open-label single-arm study.
Beran RG; Berkovic SF; Black AB; Danta G; Hiersemenzel R; Schapel GJ; Vajda FJ
Epilepsy Res; 2005 Jan; 63(1):1-9. PubMed ID: 15716083
[TBL] [Abstract][Full Text] [Related]
80. Efficacy and safety of levetiracetam in the treatment of Panayiotopoulos syndrome.
García C; Rubio G
Epilepsy Res; 2009 Aug; 85(2-3):318-20. PubMed ID: 19423296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
